It has been reported that miR-425 promoted invasion and metastasis in hepatocellular carcinoma via modulation of SCAI, while it inhibited melanoma metastasis by negatively regulating IGF-1 through repression of PI3K-Akt pathway 25,26. Here, SCAI is linked to melanoma.